arrow
W

William Vainchenker

INSERM
H指数:109
被引数:4.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors

MCM8和MCM9缺乏导致终生的造血DNA损伤增加,进而驱动p53依赖性髓系肿瘤的发生。

2025-12-180
OAAI
Casein Kinase 1α essentially regulates thrombopoiesis by driving megakaryocyte maturation and cytoskeleton organization

Casein Kinase 1α 通过驱动巨核细胞成熟和细胞骨架组织来基本调控血小板生成。

Blood
IF23.1
2025-08-050
OA
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms

JAK2 抑制介导了骨髓增殖性肿瘤中 RAS 通路突变的克隆选择。

2025-07-080
OAAI
Monocytes generated by interleukin-6-treated human hematopoietic stem and progenitor cells secrete calprotectin that inhibits erythropoiesis

由白介素-6处理的造血干细胞和祖细胞生成的单核细胞分泌钙卫蛋白,该物质抑制红细胞生成。

2025-01-010
PRE
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+v2.0 over MYSEC-PM
2024-01-264
OAAI
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
LEUKEMIA
IF13.4
2023-12-278
PRE
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution

单细胞多组学将慢性炎症确定为TP53-mutant白血病演变的驱动因素

2023-09-0439
OAAI
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice
LEUKEMIA
IF13.4
2023-04-263
OA
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis
2023-02-163
OAAI
Biological drivers of clinical phenotype in myelofibrosis
LEUKEMIA
IF13.4
2022-11-2422
OAAI
Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model
2022-07-1517
OAAI
RETRACTED: In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target (Retracted Article)
2022-03-151
OA
Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes
2022-02-0317
OAAI